Kim Ji Yoon, Kang Seung Joo
Department of Internal Medicine, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Korean J Helicobacter Up Gastrointest Res. 2025 Sep;25(3):224-233. doi: 10.7704/kjhugr.2025.0039. Epub 2025 Sep 1.
Gastric subepithelial tumors (SETs) are being increasingly detected owing to the widespread use of endoscopy. These lesions vary in etiology, with gastrointestinal stromal tumors (GISTs), leiomyomas, and ectopic pancreas among the most common types. Because some gastric SETs, such as GISTs, have malignant potential, the development of an appropriate management plan is crucial. However, the management of gastric SETs remains challenging owing to the limited information available regarding their natural courses. In this review, currently available studies were analyzed to summarize the existing evidence on the natural history and progression of gastric SETs based on initial tumor sizes and endoscopic ultrasound (EUS) features, highlighting that most small SETs (<30 mm in size) remain stable over time. Larger initial tumor sizes and irregular tumor margins, determined during EUS, are key risk factors for tumor progression. Other factors, such as older patient age, tumor location, and certain echogenic characteristics, have also been suggested to be associated with tumor progression. Additionally, tumor doubling times provide valuable information for distinguishing aggressive tumors, with high-risk GISTs demonstrating rapid growth. Surveillance strategies should be individualized based on these factors. Regular endoscopic or EUS follow-up is generally recommended for small asymptomatic SETs, with closer monitoring of lesions exhibiting high-risk features.
由于内镜检查的广泛应用,胃上皮下肿瘤(SETs)的检出率日益增加。这些病变病因各异,最常见的类型包括胃肠道间质瘤(GISTs)、平滑肌瘤和异位胰腺。由于一些胃SETs,如GISTs,具有恶性潜能,因此制定合适的管理计划至关重要。然而,由于关于胃SETs自然病程的可用信息有限,其管理仍然具有挑战性。在本综述中,分析了现有研究,以总结基于初始肿瘤大小和内镜超声(EUS)特征的胃SETs自然史和进展的现有证据,强调大多数小SETs(大小<30 mm)随时间推移保持稳定。EUS检查时确定的较大初始肿瘤大小和不规则肿瘤边缘是肿瘤进展的关键危险因素。其他因素,如患者年龄较大、肿瘤位置和某些回声特征,也被认为与肿瘤进展有关。此外,肿瘤倍增时间为区分侵袭性肿瘤提供了有价值的信息,高危GISTs生长迅速。应根据这些因素制定个体化的监测策略。对于无症状的小SETs,一般建议定期进行内镜或EUS随访,对具有高危特征的病变进行密切监测。